Given the dependency of cancer cells on glucose metabolism, researchers are exploring therapeutic strategies that target glycolysis and related pathways. Inhibitors of key enzymes like Glucose Transporters (GLUTs) and Lactate Dehydrogenase (LDH) are being investigated to disrupt the metabolic flexibility of cancer cells.
